Feasibility and Benchmarking of RiboTite gene expression control technology

我们开发了一种新的基因表达技术，可应用于研发试剂盒市场和生物制药生产。我们计划通过目前的研究，将我们的表达技术与目前市场上可用的系统进行基准测试。这项研究将展示我们技术的技术优势的关键领域，告知其在市场上的后续定位，告知我们的业务规划，并作为私募股权投资的启动引物。这笔赠款的产出将导致与行业的合作，为BBSRC资助的研究提供影响，并可能为英国创造财富和就业机会。

We have developed a novel gene expression technology that has applications in the R&D kits market and in the manufacture of biopharmaceuticals. We plan through this current study to benchmark our expression technology against those systems currently available in the marketplace. This study will showcase the key areas of technical superiority of our technology, inform its subsequent positioning in the market place, inform our business planning and act as an enabling primer for private equity investment. The outputs from this grant will lead to partnering collaborations with industry, provide impact for BBSRC funded research, and potentially lead to wealth generation and job creation for the UK.